Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy

por Cai, Yu, Chen, Rui, Gao, Shenghan, Li, Wenqing, Liu, Yuru, Su, Guodong, Song, Mingming, Jiang, Mengju, Jiang, Chao, Zhang, Xi
Publicado 2023

Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases

por Yu, Yi, Yan, Yuan, Niu, Fanglin, Wang, Yajun, Chen, Xueyi, Su, Guodong, Liu, Yuru, Zhao, Xiling, Qian, Lu, Liu, Ping, Xiong, Yuyan
Publicado 2021

The advanced development of molecular targeted therapy for hepatocellular carcinoma

por Yan, Tao, Yu, Lingxiang, Zhang, Ning, Peng, Caiyun, Su, Guodong, Jing, Yi, Zhang, Linzhi, Wu, Tong, Cheng, Jiamin, Guo, Qian, Shi, Xiaoliang, Lu, Yinying
Publicado 2022

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients

por Yan, Tao, Huang, Chenyang, Lei, Jin, Guo, Qian, Su, Guodong, Wu, Tong, Jin, Xueyuan, Peng, Caiyun, Cheng, Jiamin, Zhang, Linzhi, Liu, Zherui, Kin, Terence, Ying, Fan, Liangpunsakul, Suthat, Li, Yinyin, Lu, Yinying
Publicado 2022

A multi-center retrospective study on the efficacy and safety of regorafenib vs. regorafenib combined with PD-1 inhibitors as a second-line therapy in patients with advanced hepato...

por Yan, Tao, Huang, Chenyang, Peng, Caiyun, Duan, Xuezhang, Ji, Dong, Duan, Youjia, Zhang, Wen, Zhao, Haitao, Gao, Kun, Yang, Xiangyu, Zhang, Linzhi, Cheng, Jiamin, de Castria, Tiago Biachi, Pocha, Christine, Tsilimigras, Diamantis I., Wu, Tong, Su, Guodong, Li, Yinyin, Yu, Lingxiang, Lu, Yinying
Publicado 2023